Related Experiment Videos
Poly(A) polymerase phosphorylation is dependent on novel interactions with cyclins
G L Bond1, C Prives, J L Manley
1Department of Biological Sciences, Columbia University, New York, New York 10027, USA.
Molecular and Cellular Biology
|June 24, 2000
Summary
Poly(A) polymerase (PAP) interacts with cell cycle cyclins via a novel cyclin recognition motif (CRM). This interaction, regulated by cyclin-dependent kinases, influences PAP activity differently based on CRM peptide concentration.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Enzymology
Background:
- Poly(A) polymerase (PAP) is known to be negatively regulated by cyclin B-cdc2 kinase hyperphosphorylation during M phase.
- Cyclin recognition motif (CRM) sequences typically mediate interactions with G(1)-phase cyclins in cell cycle regulators.
Purpose of the Study:
- To investigate the direct interaction between poly(A) polymerase (PAP) and cyclin B(1).
- To characterize the role of a novel cyclin recognition motif (CRM) in PAP's interaction with different cyclin types and its functional consequences.
Main Methods:
- Direct binding assays to confirm PAP-cyclin B(1) interaction.
- Analysis of PAP's amino acid sequence for homology to cyclin recognition motifs (CRM).
- In vitro kinase assays using cyclin-cdk pairs and PAP, including experiments with CRM peptides at varying concentrations.
Main Results:
- Direct binding between PAP and cyclin B(1) was demonstrated, mediated by a CRM in PAP.
- PAP's CRM interacts with both G(1)- and G(2)-type cyclins and is a substrate for phosphorylation by cyclin-cdk pairs.
- PAP's CRM peptide exhibits concentration-dependent effects: high concentrations inhibit binding and phosphorylation, while low concentrations stimulate these activities.
Conclusions:
- Poly(A) polymerase (PAP) is directly regulated by cyclin-dependent kinases throughout the cell cycle.
- A novel type of CRM in PAP functionally interacts with both G(1)- and G(2)-type cyclins in a concentration-dependent manner, revealing a new regulatory mechanism.